Anzeige
Mehr »
Login
Donnerstag, 02.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Paukenschlag in USA: Cannabis-Neuregulierung durch DEA sorgt für Kursexplosion!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
51 Leser
Artikel bewerten:
(0)

Med-Emerg International Inc. reports improved income from continuing operations

TORONTO, May 12 /PRNewswire-FirstCall/ -- Med-Emerg International Inc. (OTCBB - MDER), announced today that revenue from continuing operations, for the three months ended March 31, 2008 were $5.5 million compared to $4.8 million for the same period in 2007 (all amounts are $US unless otherwise stated). For the three month period, earnings before depreciation, amortization, interest and taxes (EBITDA) improved to $179K from a loss of ($106K) in 2007. The improvement in EBITDA arose largely as a result of improved performance in the Infusions Services division. Losses in Pain Management decreased to ($201K) in 2008 from ($234K) in 2007. The Staffing Solutions division reported income of $9K compared to a loss of ($27K) in 2007.

The Company reported a Loss attributable to common shareholders in the quarter of ($6K) ($0.000 per share) in 2008, compared to a loss of ($287K) ($0.005 per share) in 2007.

The Company's financial statement information is summarized below: (US$000's except share information) Three Months Ended March 31 -------------------------- 2008 2007 Revenue 5,465 4,822 EBITDA 179 (106) Income (loss) from continuing operations 81 (175) Loss from discontinued operations (87) (113) Net income (loss) attributable to common shareholders (6) (287) Net income (loss) per common share (basis and diluted) Continuing operations 0.001 (0.003) Discontinued operations (0.001) (0.002) Weighted average shares outstanding, basic (millions) 58,277,696 58,277,696 (US$000's) March December 31, 31, 2008 2007 -------------------------- Balance Sheet Data: -------------------------- Working Capital Surplus 2,436 2,472 Total Assets 7,440 7,529 Long-term debt 397 445 Shareholders' equity - Canadian GAAP 837 880 Shareholders' equity - US GAAP 802 926

MedEmerg specializes in the coordination and delivery of health care services in Canada and overseas. These services include an integrated chronic pain management program, community-based infusion centers and health human resource management, including physician and nurse staffing.

All statements included in this press release that are not statements of historical fact are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "plan", "expect", "believe", "intend", "anticipate", "forecast", "target", "estimate" and similar expressions identify forward-looking statements. Forward-looking statements are based on assumptions made by and information currently available to the Company. Investors are cautioned that these forward-looking statements are neither promises nor guarantees, and are subject to risks and uncertainties that may cause future results to differ materially from those expected. These risks and uncertainties are outlined in the Company's Annual Report on Form 10-K for 2007, and such other documents as are filed with the Securities and Exchange Commission from time to time. The Company does not undertake to review or update these forward-looking statements. The Company qualifies all of the information contained in this press release, and particularly its forward-looking statements, by these cautionary statements.

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2008 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.